KYOTO, JAPAN, SEPTEMBER 9, 2010- Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company (NYSE:GE) is showcasing a comprehensive molecular imaging portfolio---encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment--- to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
business unit
tags
Investigational MBI system in clinical trials at two major cancer research centers outside the U.S.*
SALT LAKE CITY, UT, JUNE 6, 2010 -- GE Healthcare, a unit of General Electric Company (NYSE:GE), announced its collaboration in two clinical trials with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and Hamilton Health Sciences Hospital in Ontario, Canada on the use of a novel technology that may assist in assessment and early detection of breast cancer in women who are at high risk for the disease.